10.38BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US82937X1037
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
32.69
PEG Ratio
2.85
Book Value
1.78
Dividend Share
0.065
Dividend Yield
1.89%
Earnings Share
0.29
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
28,866,158,592
Gross Profit TTM
23,529,940,992
EBITDA
6,892,781,056
Profit Margin
12.12%
Return On Assets TTM
5.62%
Return On Equity TTM
11.82%
Revenue Per Share TTM
31.56
Qtly Revenue Growth YOY
11.10%
Diluted Eps TTM
0.29
Qtly Earnings Growth YOY
141.70%
Trailing PE
32.69
Forward PE
21
Price Sales TTM
0.4367
Price Book MRQ
1.9091
Enterprise Value Revenue
2
Enterprise Value EBITDA
12
160.00
3.92%79.89
0.99%252.26
0.80%100.98
0.72%315.75
0.25%561.34
0.16%547.60
0.00%203.85
0.00%569.62
-0.20%471.50
-0.20%